 | • レポートコード：QFJ1-4749 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、予測的発症前検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分子検査、細胞原検査、生化学的検査）、用途別市場規模（乳がん・卵巣がん、結腸直腸がん、アルツハイマー病、多発性内分泌腺腫症2型、ヘモクロマトーシス）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・予測的発症前検査の市場動向 ・企業の競争状況、市場シェア ・予測的発症前検査の種類別市場規模と予測2016-2027（分子検査、細胞原検査、生化学的検査） ・予測的発症前検査の用途別市場規模と予測2016-2027（乳がん・卵巣がん、結腸直腸がん、アルツハイマー病、多発性内分泌腺腫症2型、ヘモクロマトーシス） ・予測的発症前検査の北米市場規模2016-2027（アメリカ、カナダ） ・予測的発症前検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・予測的発症前検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・予測的発症前検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・予測的発症前検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（23andMe, Inc.、Abbott Laboratories、Bayer HealthCare AG、Biocartis SA、BioHelix Corporation、bioMerieux S.A.、Celera Corporation (Quest Diagnostics)、Cepheid (Danaher)、Daan Diagnostics Ltd.、EKF Diagnostics Holdings plc） ・結論 |
Market Analysis and Insights: Global Predictive Presymptomatic Testing Market
The global Predictive Presymptomatic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Predictive Presymptomatic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Predictive Presymptomatic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Predictive Presymptomatic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Predictive Presymptomatic Testing market.
Global Predictive Presymptomatic Testing Scope and Market Size
Predictive Presymptomatic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Predictive Presymptomatic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Molecular Testing
Cytogenic Testing
Biochemical Testing
Segment by Application
Breast and Ovarian Cancer
Colorectal Cancer
Alzheimer’s Disease
Multiple Endocrine Neoplasia Type 2
Haemochromatosis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
23andMe, Inc.
Abbott Laboratories
Bayer HealthCare AG
Biocartis SA
BioHelix Corporation
bioMerieux S.A.
Celera Corporation (Quest Diagnostics)
Cepheid (Danaher)
Daan Diagnostics Ltd.
EKF Diagnostics Holdings plc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Testing
1.2.3 Cytogenic Testing
1.2.4 Biochemical Testing
1.3 Market by Application
1.3.1 Global Predictive Presymptomatic Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast and Ovarian Cancer
1.3.3 Colorectal Cancer
1.3.4 Alzheimer’s Disease
1.3.5 Multiple Endocrine Neoplasia Type 2
1.3.6 Haemochromatosis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Predictive Presymptomatic Testing Market Perspective (2016-2027)
2.2 Predictive Presymptomatic Testing Growth Trends by Regions
2.2.1 Predictive Presymptomatic Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Predictive Presymptomatic Testing Historic Market Share by Regions (2016-2021)
2.2.3 Predictive Presymptomatic Testing Forecasted Market Size by Regions (2022-2027)
2.3 Predictive Presymptomatic Testing Industry Dynamic
2.3.1 Predictive Presymptomatic Testing Market Trends
2.3.2 Predictive Presymptomatic Testing Market Drivers
2.3.3 Predictive Presymptomatic Testing Market Challenges
2.3.4 Predictive Presymptomatic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Predictive Presymptomatic Testing Players by Revenue
3.1.1 Global Top Predictive Presymptomatic Testing Players by Revenue (2016-2021)
3.1.2 Global Predictive Presymptomatic Testing Revenue Market Share by Players (2016-2021)
3.2 Global Predictive Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Predictive Presymptomatic Testing Revenue
3.4 Global Predictive Presymptomatic Testing Market Concentration Ratio
3.4.1 Global Predictive Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Predictive Presymptomatic Testing Revenue in 2020
3.5 Predictive Presymptomatic Testing Key Players Head office and Area Served
3.6 Key Players Predictive Presymptomatic Testing Product Solution and Service
3.7 Date of Enter into Predictive Presymptomatic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Predictive Presymptomatic Testing Breakdown Data by Type
4.1 Global Predictive Presymptomatic Testing Historic Market Size by Type (2016-2021)
4.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2022-2027)
5 Predictive Presymptomatic Testing Breakdown Data by Application
5.1 Global Predictive Presymptomatic Testing Historic Market Size by Application (2016-2021)
5.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Predictive Presymptomatic Testing Market Size (2016-2027)
6.2 North America Predictive Presymptomatic Testing Market Size by Type
6.2.1 North America Predictive Presymptomatic Testing Market Size by Type (2016-2021)
6.2.2 North America Predictive Presymptomatic Testing Market Size by Type (2022-2027)
6.2.3 North America Predictive Presymptomatic Testing Market Size by Type (2016-2027)
6.3 North America Predictive Presymptomatic Testing Market Size by Application
6.3.1 North America Predictive Presymptomatic Testing Market Size by Application (2016-2021)
6.3.2 North America Predictive Presymptomatic Testing Market Size by Application (2022-2027)
6.3.3 North America Predictive Presymptomatic Testing Market Size by Application (2016-2027)
6.4 North America Predictive Presymptomatic Testing Market Size by Country
6.4.1 North America Predictive Presymptomatic Testing Market Size by Country (2016-2021)
6.4.2 North America Predictive Presymptomatic Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Predictive Presymptomatic Testing Market Size (2016-2027)
7.2 Europe Predictive Presymptomatic Testing Market Size by Type
7.2.1 Europe Predictive Presymptomatic Testing Market Size by Type (2016-2021)
7.2.2 Europe Predictive Presymptomatic Testing Market Size by Type (2022-2027)
7.2.3 Europe Predictive Presymptomatic Testing Market Size by Type (2016-2027)
7.3 Europe Predictive Presymptomatic Testing Market Size by Application
7.3.1 Europe Predictive Presymptomatic Testing Market Size by Application (2016-2021)
7.3.2 Europe Predictive Presymptomatic Testing Market Size by Application (2022-2027)
7.3.3 Europe Predictive Presymptomatic Testing Market Size by Application (2016-2027)
7.4 Europe Predictive Presymptomatic Testing Market Size by Country
7.4.1 Europe Predictive Presymptomatic Testing Market Size by Country (2016-2021)
7.4.2 Europe Predictive Presymptomatic Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Predictive Presymptomatic Testing Market Size (2016-2027)
8.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type
8.2.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application
8.3.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region
8.4.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Predictive Presymptomatic Testing Market Size (2016-2027)
9.2 Latin America Predictive Presymptomatic Testing Market Size by Type
9.2.1 Latin America Predictive Presymptomatic Testing Market Size by Type (2016-2021)
9.2.2 Latin America Predictive Presymptomatic Testing Market Size by Type (2022-2027)
9.2.3 Latin America Predictive Presymptomatic Testing Market Size by Type (2016-2027)
9.3 Latin America Predictive Presymptomatic Testing Market Size by Application
9.3.1 Latin America Predictive Presymptomatic Testing Market Size by Application (2016-2021)
9.3.2 Latin America Predictive Presymptomatic Testing Market Size by Application (2022-2027)
9.3.3 Latin America Predictive Presymptomatic Testing Market Size by Application (2016-2027)
9.4 Latin America Predictive Presymptomatic Testing Market Size by Country
9.4.1 Latin America Predictive Presymptomatic Testing Market Size by Country (2016-2021)
9.4.2 Latin America Predictive Presymptomatic Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Predictive Presymptomatic Testing Market Size (2016-2027)
10.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type
10.2.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application
10.3.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country
10.4.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 23andMe, Inc.
11.1.1 23andMe, Inc. Company Details
11.1.2 23andMe, Inc. Business Overview
11.1.3 23andMe, Inc. Predictive Presymptomatic Testing Introduction
11.1.4 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.1.5 23andMe, Inc. Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Predictive Presymptomatic Testing Introduction
11.2.4 Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.2.5 Abbott Laboratories Recent Development
11.3 Bayer HealthCare AG
11.3.1 Bayer HealthCare AG Company Details
11.3.2 Bayer HealthCare AG Business Overview
11.3.3 Bayer HealthCare AG Predictive Presymptomatic Testing Introduction
11.3.4 Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.3.5 Bayer HealthCare AG Recent Development
11.4 Biocartis SA
11.4.1 Biocartis SA Company Details
11.4.2 Biocartis SA Business Overview
11.4.3 Biocartis SA Predictive Presymptomatic Testing Introduction
11.4.4 Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.4.5 Biocartis SA Recent Development
11.5 BioHelix Corporation
11.5.1 BioHelix Corporation Company Details
11.5.2 BioHelix Corporation Business Overview
11.5.3 BioHelix Corporation Predictive Presymptomatic Testing Introduction
11.5.4 BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.5.5 BioHelix Corporation Recent Development
11.6 bioMerieux S.A.
11.6.1 bioMerieux S.A. Company Details
11.6.2 bioMerieux S.A. Business Overview
11.6.3 bioMerieux S.A. Predictive Presymptomatic Testing Introduction
11.6.4 bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.6.5 bioMerieux S.A. Recent Development
11.7 Celera Corporation (Quest Diagnostics)
11.7.1 Celera Corporation (Quest Diagnostics) Company Details
11.7.2 Celera Corporation (Quest Diagnostics) Business Overview
11.7.3 Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Introduction
11.7.4 Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.7.5 Celera Corporation (Quest Diagnostics) Recent Development
11.8 Cepheid (Danaher)
11.8.1 Cepheid (Danaher) Company Details
11.8.2 Cepheid (Danaher) Business Overview
11.8.3 Cepheid (Danaher) Predictive Presymptomatic Testing Introduction
11.8.4 Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.8.5 Cepheid (Danaher) Recent Development
11.9 Daan Diagnostics Ltd.
11.9.1 Daan Diagnostics Ltd. Company Details
11.9.2 Daan Diagnostics Ltd. Business Overview
11.9.3 Daan Diagnostics Ltd. Predictive Presymptomatic Testing Introduction
11.9.4 Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.9.5 Daan Diagnostics Ltd. Recent Development
11.10 EKF Diagnostics Holdings plc
11.10.1 EKF Diagnostics Holdings plc Company Details
11.10.2 EKF Diagnostics Holdings plc Business Overview
11.10.3 EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Introduction
11.10.4 EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2016-2021)
11.10.5 EKF Diagnostics Holdings plc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Predictive Presymptomatic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Molecular Testing
Table 3. Key Players of Cytogenic Testing
Table 4. Key Players of Biochemical Testing
Table 5. Global Predictive Presymptomatic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Predictive Presymptomatic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Predictive Presymptomatic Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Predictive Presymptomatic Testing Market Share by Regions (2016-2021)
Table 9. Global Predictive Presymptomatic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Predictive Presymptomatic Testing Market Share by Regions (2022-2027)
Table 11. Predictive Presymptomatic Testing Market Trends
Table 12. Predictive Presymptomatic Testing Market Drivers
Table 13. Predictive Presymptomatic Testing Market Challenges
Table 14. Predictive Presymptomatic Testing Market Restraints
Table 15. Global Predictive Presymptomatic Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Predictive Presymptomatic Testing Market Share by Players (2016-2021)
Table 17. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Predictive Presymptomatic Testing as of 2020)
Table 18. Ranking of Global Top Predictive Presymptomatic Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Predictive Presymptomatic Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Predictive Presymptomatic Testing Product Solution and Service
Table 22. Date of Enter into Predictive Presymptomatic Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Predictive Presymptomatic Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Predictive Presymptomatic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Predictive Presymptomatic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Predictive Presymptomatic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Predictive Presymptomatic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Predictive Presymptomatic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Predictive Presymptomatic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. 23andMe, Inc. Company Details
Table 63. 23andMe, Inc. Business Overview
Table 64. 23andMe, Inc. Predictive Presymptomatic Testing Product
Table 65. 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 66. 23andMe, Inc. Recent Development
Table 67. Abbott Laboratories Company Details
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Predictive Presymptomatic Testing Product
Table 70. Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 71. Abbott Laboratories Recent Development
Table 72. Bayer HealthCare AG Company Details
Table 73. Bayer HealthCare AG Business Overview
Table 74. Bayer HealthCare AG Predictive Presymptomatic Testing Product
Table 75. Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 76. Bayer HealthCare AG Recent Development
Table 77. Biocartis SA Company Details
Table 78. Biocartis SA Business Overview
Table 79. Biocartis SA Predictive Presymptomatic Testing Product
Table 80. Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 81. Biocartis SA Recent Development
Table 82. BioHelix Corporation Company Details
Table 83. BioHelix Corporation Business Overview
Table 84. BioHelix Corporation Predictive Presymptomatic Testing Product
Table 85. BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 86. BioHelix Corporation Recent Development
Table 87. bioMerieux S.A. Company Details
Table 88. bioMerieux S.A. Business Overview
Table 89. bioMerieux S.A. Predictive Presymptomatic Testing Product
Table 90. bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 91. bioMerieux S.A. Recent Development
Table 92. Celera Corporation (Quest Diagnostics) Company Details
Table 93. Celera Corporation (Quest Diagnostics) Business Overview
Table 94. Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Product
Table 95. Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 96. Celera Corporation (Quest Diagnostics) Recent Development
Table 97. Cepheid (Danaher) Company Details
Table 98. Cepheid (Danaher) Business Overview
Table 99. Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 100. Cepheid (Danaher) Recent Development
Table 101. Daan Diagnostics Ltd. Company Details
Table 102. Daan Diagnostics Ltd. Business Overview
Table 103. Daan Diagnostics Ltd. Predictive Presymptomatic Testing Product
Table 104. Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 105. Daan Diagnostics Ltd. Recent Development
Table 106. EKF Diagnostics Holdings plc Company Details
Table 107. EKF Diagnostics Holdings plc Business Overview
Table 108. EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Product
Table 109. EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million)
Table 110. EKF Diagnostics Holdings plc Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Predictive Presymptomatic Testing Market Share by Type: 2020 VS 2027
Figure 2. Molecular Testing Features
Figure 3. Cytogenic Testing Features
Figure 4. Biochemical Testing Features
Figure 5. Global Predictive Presymptomatic Testing Market Share by Application: 2020 VS 2027
Figure 6. Breast and Ovarian Cancer Case Studies
Figure 7. Colorectal Cancer Case Studies
Figure 8. Alzheimer's Disease Case Studies
Figure 9. Multiple Endocrine Neoplasia Type 2 Case Studies
Figure 10. Haemochromatosis Case Studies
Figure 11. Predictive Presymptomatic Testing Report Years Considered
Figure 12. Global Predictive Presymptomatic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Predictive Presymptomatic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Predictive Presymptomatic Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global Predictive Presymptomatic Testing Market Share by Regions (2022-2027)
Figure 16. Global Predictive Presymptomatic Testing Market Share by Players in 2020
Figure 17. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Predictive Presymptomatic Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Predictive Presymptomatic Testing Revenue in 2020
Figure 19. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Predictive Presymptomatic Testing Market Share by Type (2016-2027)
Figure 23. North America Predictive Presymptomatic Testing Market Share by Application (2016-2027)
Figure 24. North America Predictive Presymptomatic Testing Market Share by Country (2016-2027)
Figure 25. United States Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Predictive Presymptomatic Testing Market Share by Type (2016-2027)
Figure 29. Europe Predictive Presymptomatic Testing Market Share by Application (2016-2027)
Figure 30. Europe Predictive Presymptomatic Testing Market Share by Country (2016-2027)
Figure 31. Germany Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Predictive Presymptomatic Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Predictive Presymptomatic Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Predictive Presymptomatic Testing Market Share by Region (2016-2027)
Figure 41. China Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Predictive Presymptomatic Testing Market Share by Type (2016-2027)
Figure 49. Latin America Predictive Presymptomatic Testing Market Share by Application (2016-2027)
Figure 50. Latin America Predictive Presymptomatic Testing Market Share by Country (2016-2027)
Figure 51. Mexico Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Predictive Presymptomatic Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Predictive Presymptomatic Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Predictive Presymptomatic Testing Market Share by Country (2016-2027)
Figure 57. Turkey Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. 23andMe, Inc. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 61. Abbott Laboratories Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 62. Bayer HealthCare AG Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 63. Biocartis SA Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 64. BioHelix Corporation Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 65. bioMerieux S.A. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 66. Celera Corporation (Quest Diagnostics) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 67. Cepheid (Danaher) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 68. Daan Diagnostics Ltd. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 69. EKF Diagnostics Holdings plc Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の乳がん検査市場規模・現状・予測（2021年-2027年） Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…- 予測遺伝子検査及び消費者/ウェルネスゲノミクスのグローバル市場調査 2019年 The global Predictive Genetic Testing And Consumer/Wellness Genomics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Predictive Genetic Testing And Consumer/Wellness Genomics volume and value at glo…
- 予測遺伝子検査及び消費者/ウェルネスゲノミクスのグローバル市場調査 2019年 The global Predictive Genetic Testing And Consumer/Wellness Genomics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Predictive Genetic Testing And Consumer/Wellness Genomics volume and value at glo…
- 乳がん検査のグローバル市場：規模・現状・予測2019-2025 Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…
- 乳がん検査のグローバル市場：規模・現状・予測2019-2025 Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…